Clinical trial Recruiting at 1 site Observational

Virus interactions in hospitalized patients during winter seasons in Lyon

Official title: Virus-virus Interactions Among Patients Admitted to the Hospices Civils de Lyon, During 2022 to 2025 Winters Seasons

Run by Hospices Civils de Lyon · NCT07805590 · Data updated 2026-11-12

This study tests all virological results from hospitalized patients in Lyon during winter to see how different respiratory viruses may co-occur or exclude each other.

Quick facts

Study typeObservational
SexAll
Enrollment114230 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations1 site (Lyon, Rhone)
StatusRecruiting
StartedJanuary 5, 2026
Main results expectedMay 31, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 4, 2026
Trial IDNCT07805590 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Hospitals in Lyon (Croix-Rousse) and Infective Agents Institute patients of any age with a virological test for a respiratory infection during winter periods 2022–2025.

Probably not a fit

Patients whose samples do not yield detectable viruses or whose illnesses are unrelated to co-infection dynamics may not benefit from findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study analyzes routine diagnostic virology results from patients admitted to Hospices Civils de Lyon during winter seasons from 2022 to 2025. It aims to describe how common co-detections or mutual exclusions occur among respiratory viruses and how these patterns relate to disease severity. The approach combines epidemiology, clinical observations, and in vitro findings to explore population-level virus–virus interactions and their potential impact on patient outcomes. The study uses data from routine care samples without experimental interventions. Results may help inform understanding of viral dynamics and guide public health insights for respiratory infections.

Why it matters

Potential benefit: If successful, the study could improve understanding of how co-infections influence illness and help clinicians anticipate patterns of respiratory viral activity.

How similar studies have gone: Previous work has shown both negative interactions (mutual exclusion) and complex dynamics between respiratory viruses, supporting the relevance of population-level analyses.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* \- Any virological result (positive or negative) following a biological sample taken as part of routine care within the HCLs for the purpose of diagnosing a respiratory infection in a hospitalised patient.
* Patients of any age
* Samples taken during the winter periods between 2022 and 2025.

Exclusion Criteria:

* na

Where it's running

  • Infective Agents Institute, Croix rousse Hospital
    Lyon, Rhone, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.